7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hydromorphone-OROS formulation.

      1
      Expert opinion on pharmacotherapy
      Informa Healthcare

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hydromorphone is a semi-synthetic opioid approved in the USA for the treatment and relief of moderate to severe pain and postoperative pain. However, the compound is short-acting, and there is no extended-release formulation clinically available. A previous hydromorphone extended-release formulation that successfully came to market was subsequently withdrawn on account of safety concerns. Clinical need supports the presence of an extended-release formulation of hydromorphone.

          Related collections

          Author and article information

          Journal
          Expert Opin Pharmacother
          Expert opinion on pharmacotherapy
          Informa Healthcare
          1744-7666
          1465-6566
          May 2010
          : 11
          : 7
          Affiliations
          [1 ] Duke University Medical Center, DUMC 3309, Durham, NC 27710, USA. harold.goforth@duke.edu
          Article
          10.1517/14656566.2010.482099
          20402557
          4dc64143-a86f-412e-a378-8074b9a9c02c
          History

          Comments

          Comment on this article